Browsing Centre for Immunobiology by Author "Tam, E"
Now showing items 1-2 of 2
-
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Zeuzem, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, H (2018-01-25) -
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial
Dore, GJ; Feld, JJ; Thompson, A; Martinello, M; Muir, AJ; Agarwal, K; Mullhaupt, B; Wedemeyer, H; Lacombe, K; Matthews, GV (2020-03)